Patents by Inventor Jose L. Castro
Jose L. Castro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12212362Abstract: An apparatus having input and output ports using a plurality of optical connector adapters, wherein the fiber connections can follow a specific mesh pattern has a plurality of fibers inside the apparatus. The fibers pass through at least one mandrel and are designed to produce a leakage in the transmitted light from each fiber of least ?30 dBm, wherein the fiber buffer of fibers around the mandrel are partially stripped in at least one section. The apparatus also has an imaging system consisting of at least a lens, camera sensor and an optical filter are placed in proximity to the fiber striped section wherein the optical filter has spectral properties tuned or partially tuned to the operational wavelength of the network and the optical filter is placed in the light path before the camera sensor.Type: GrantFiled: December 1, 2022Date of Patent: January 28, 2025Assignee: Panduit Corp.Inventors: Jose M. Castro, Yu Huang, Bulent Kose, Asher S. Novick, Kevin A. Marley, Brian L Kelly
-
Publication number: 20250030225Abstract: A method and apparatus for repurposing a communications zone enclosure including providing an input power source within a telecommunications room, providing circuitry configured to split the power of the input source into a plurality of channels, using preexisting twisted pair communication cables to transmit power from the plurality of channels to the zone enclosure, and recombining power the power into a single output power source.Type: ApplicationFiled: July 17, 2023Publication date: January 23, 2025Applicant: Panduit Corp.Inventors: Jose M. Castro, Bulent Kose, George F. Einterz, Kevin A. Marley, Brian L. Kelly
-
Patent number: 5618812Abstract: Compounds of Formula (I), and salts and prodrugs thereof, wherein R.sup.1 represents H, optionally substituted C.sub.1-6 alkyl or C.sub.3-7 cycloalkyl; R.sup.2 is NHR.sup.12 or (CH.sub.2).sub.s R.sup.13 where 5 is 0, 1 or 2; R.sup.3 represents C.sub.1-6 alkyl, halo or NR.sup.6 R.sup.7 ; R.sup.4 and R.sup.5 are H, C.sub.1-12 alkyl optionally substituted by NR.sup.9 R.sup.9' or an azacyclic or azabicyclic group, optionally substituted C.sub.4-9 cycloalkyl, C.sub.4-9 cycloalkyl C.sub.1-4 alkyl, aryl, arylC.sub.1-6 alkyl or azacyclic or azabicyclic groups, or R.sup.4 and R.sup.5 together form the residue of an optionally substituted azacyclic or azabicyclic ring system; x is 0, 1, 2 or 3; R.sup.12 is optionally substituted phenyl or pyridyl; R.sup.13 represents a group (A) wherein R.sup.14 is H or C.sub.1-6 alkyl; R.sup.15 is H, C.sub.1-6 alkyl, halo or NR.sup.6 R.sup.7 ; and the dotted line is an optional covalent bond; are CCK and/or gastrin antagonists useful in therapy.Type: GrantFiled: January 26, 1995Date of Patent: April 8, 1997Assignee: Merck Sharp & Dohme, Ltd.Inventors: Jose L. Castro Pineiro, William R. Carling, Mark S. Chambers, Stephen R. Fletcher, Sarah C. Hobbs, Victor G. Matassa, Kevin W. Moore, Graham A. Showell, Michael G. Russell
-
Patent number: 5607957Abstract: A class of substituted imidazole, triazole and tetrazole derivatives are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.Type: GrantFiled: September 29, 1994Date of Patent: March 4, 1997Assignee: Merck Sharp & Dohme Ltd.Inventors: Jose L. Castro Pineiro, Victor G. Matassa
-
Patent number: 5567726Abstract: Imidazole, triazole and tetrazole derivatives of formula (I) are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated, wherein the broken circle represents two non-adjacent double bonds in any position in the five-membered ring; two, three or four of V, W, X, Y and Z represent nitrogen and the remainder represent carbon provided that, when two of V, W, X, Y and Z represent nitrogen and the remainder represent carbon, then the said nitrogen atoms are in non-adjacent positions within the five-membered ring; E represents a bond or a straight or branched alkylene chain containing from 1 to 4 carbon atoms; F represents a group of formula (a); U represents nitrogen or C--R.sup.2 ; B represents oxygen, sulphur or N--R.sup.3 ; R.sup.1 represents a group of formula (i), (ii) or (iii).Type: GrantFiled: January 24, 1995Date of Patent: October 22, 1996Assignee: Merck, Sharp & Dohme Ltd.Inventors: Raymond Baker, Jose L. Castro Pineiro, Alexander R. Guiblin, Austin J. Reeve, Francine Sternfeld, Victor G. Matassa, Leslie J. Street
-
Patent number: 5521175Abstract: Compounds of Formula (I), and salts and prodrugs thereof, wherein R.sup.1 represents C.sub.1-6 alkyl or C.sub.3-7 cycloalkyl; R.sup.2 optionally substituted phenyl or R.sup.2 represents a group (A) where W is CH.sub.2 or NR.sup.10, and W.sup.1 is CH.sub.2, or W and W.sup.1 each represent 0; R.sup.3 is C.sub.1-6 alkyl, halo or NR.sup.13 R.sup.14 ; R.sup.4 is H, C.sub.1-4 alkyl, optionally substituted phenyl or optionally substituted benzyl; R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are H or C.sub.1-4 alkyl; or any two of R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 together form a chain (CH.sub.2).sub.t, and any other two of R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 optionally form a chain (CH.sub.2).sub.s where s and t are independently 1, 2 or 3; m is 2, 3, 4, 5, 6, 7, 8 or 9; n is 0, 1, 2, 3 or 4; and x is 0, 1, 2 or 3; are CCK and/or gastrin antagonists useful in therapy.Type: GrantFiled: January 26, 1995Date of Patent: May 28, 1996Assignee: Merck Sharp & Dohme Ltd.Inventors: Jose L. Castro Pineiro, Mark S. Chambers, Victor G. Matassa
-
Patent number: 5510359Abstract: A class of substituted five-membered heteroaromatic compounds possessing an imino spacer group are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.Type: GrantFiled: October 7, 1994Date of Patent: April 23, 1996Assignee: Merck Sharp & Dohme Ltd.Inventors: Jose L. Castro Pineiro, Victor G. Matassa
-
Patent number: 5392549Abstract: A device in combination with a driving station of a vehicle for displaying and storing a flexible web containing information wound in two cylinder members that provide sufficient slag in the web to form a loop that holds a weighting member. The weighting member is pulled away from the first two cylinders either by gravity or spring action and the web is exposed by turning at least one of the two cylinder members. The two cylinder members an be manually or electrically actuated. A user thereby views a specific area of the map or information contained in the web. An electric bulb is provided to illuminate the web from inside the loop.Type: GrantFiled: December 13, 1993Date of Patent: February 28, 1995Inventor: Jose L. Castro
-
Patent number: 5168647Abstract: A device for displaying and storing a flexible web containing information wound in two cylinder members that provide sufficient slag in the web to form a loop that holds a third cylinder member. The third cylinder member is pulled away from the first two either by gravity or spring action and the web is exposed by turning at least one of the first two cylinder members. The two cylinder members can be manually or electrically actuated. A user thereby views a specific area of the map or information contained in the web. An electric bulb is provided to illuminate the web from inside the loop created by the web.Type: GrantFiled: May 30, 1991Date of Patent: December 8, 1992Inventor: Jose L. Castro